ORAMED PHARMACEUTICALS INC.·4

Jul 18, 1:31 PM ET

Sank Leonard 4

4 · ORAMED PHARMACEUTICALS INC. · Filed Jul 18, 2019

Insider Transaction Report

Form 4
Period: 2019-07-16
Sank Leonard
Director
Transactions
  • Purchase

    Common Stock

    2019-07-16$3.47/sh+20,000$69,316315,482 total
  • Purchase

    Common Stock

    2019-07-18$3.85/sh+4,497$17,336349,999 total
  • Purchase

    Common Stock

    2019-07-17$3.58/sh+20,000$71,562335,482 total
  • Purchase

    Common Stock

    2019-07-17$3.74/sh+10,020$37,497345,502 total
Holdings
  • Common Stock

    (indirect: By Spouse)
    78,125
  • Common Stock

    (indirect: By Trust)
    138,889
Footnotes (2)
  • [F1]Mr. Sank disclaims beneficial ownership of these shares.
  • [F2]These shares consist of shares of common stock owned by a company wholly owned by a trust of which Mr. Sank is a trustee. Mr. Sank disclaims beneficial ownership of these shares.

Documents

1 file
  • 4
    ownership.xmlPrimary